MedTrace Logo

Cathelicidin LL-37 Relation to Potentially Malignant Lesions

NCT06219330 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2024-01-23

No results posted yet for this study

Summary

LL-37 appears to have a potential role in potentially malignant lesions (OLP \& leukoplakia). The remarkable diagnostic accuracy of salivary LL-37 in differentiating potentially malignant lesion and healthy control could confirm its utilization as an innovative marker to early diagnose potentially malignant lesions. Salivary LL-37 being non-invasive accurate marker could be as a chair-side diagnostic method that detect potentially malignant lesions.

Conditions

  • Oral Potentially Malignant Lesions

Sponsors & Collaborators

  • Cairo University

    collaborator OTHER

  • Fayoum University

    lead OTHER

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2023-10-30
Completion
2023-11-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06219330 on ClinicalTrials.gov